28449-40-3 ((Pregna-1,4,17(20)-trien-3-one,11,21-dihydroxy-, (11b,17Z)- (9CI))

Pregna-1,4,17(20)-trien-3-one,11,21-dihydroxy-, (11b,17Z)- (9CI);11-hydroxy-17-(2-hydroxyethylidene)-10,13-dimethyl-7,8,9,11,12,14,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one;(17E)-11-hydroxy-17-(2-hydroxyethylidene)-10,13-dimethyl-7,8,9,11,12,1 4,15,16-octahydro-6H-cyclopenta[a]phenanthren-3-one;PREGNA-1,4,17(20)-TRIEN-3-ONE, 11.BETA.,21-DIHYDROXY-, (Z)-;28449-40-3;51259-83-7;NSC 48982;NSC-48982;CHEBI:79805;PREGNA-1,4,17(20)-TRIEN-3-ONE, 11,21-DIHYDROXY-, (11.BETA.,17Z)-;11-beta,21-Dihydroxypregna-1,4,17(20)-trien-3-one;Q27148941;(Z)-11beta,21-Dihydroxypregna-1,4,17(20)-trien-3-one;UNII-893EIE1601;11,21-DIHYDROXYPREGNA-1,4,17(20)-TRIEN-3-ONE, (11.BETA.,17Z)-;EINECS 257-092-2;11,21-Dihydroxypregna-1,4,17(20)-trien-3-one, (11beta,17Z)-;(11beta,17Z)-11,21-dihydroxypregna-1,4,17(20)-trien-3-one;893EIE1601;

FIMYJWIQTVIDQB-PKJGFKEFSA-N

1S/C21H28O3/c1-20-9-7-15(23)11-14(20)3-5-16-17-6-4-13(8-10-22)21(17,2)12-18(24)19(16)20/h7-9,11,16-19,22,24H,3-6,10,12H2,1-2H3/b13-8-/t16-,17-,18-,19+,20-,21+/m0/s1

O[C@H]1C[C@]2(C)/C(=C\CO)/CC[C@H]2[C@@H]2CCC3=CC(C=C[C@]3(C)[C@H]21)=O